foxo4-dri senolytic 2024 animal model Class II senolytics inhibit survival pathways elicited by senescent FOXO4-DRI: The Senolytic Peptide That
Description
J Glaucoma 10:2531

Reports funded by national institutes of health, beyond myalgic encephalomyelitis/Chronic fatigue syndrome: redefining an illness, national academies press (US)

European Journal of Pharmacology, 833, 274289

Stefani is AMAZING

J Electronic Sci Technol

Whelton 1999
